Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors
Hilda Wong(Chinese University of Hong Kong), Richard J. Epstein(Garvan Institute of Medical Research)
Cited by 4
Related Papers
Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
|British Journal of Cancer|2010|71